Global Immuno-Oncology Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Immuno-Oncology Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Immuno-Oncology Treatment industry chain, the market status of Hospitals (Immune Checkpoint Inhibitors, Monoclonal Antibodies), Ambulatory Surgical Center (Immune Checkpoint Inhibitors, Monoclonal Antibodies), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Immuno-Oncology Treatment.

Regionally, the report analyzes the Immuno-Oncology Treatment markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Immuno-Oncology Treatment market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Immuno-Oncology Treatment market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Immuno-Oncology Treatment industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Immune Checkpoint Inhibitors, Monoclonal Antibodies).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Immuno-Oncology Treatment market.

Regional Analysis: The report involves examining the Immuno-Oncology Treatment market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Immuno-Oncology Treatment market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Immuno-Oncology Treatment:
Company Analysis: Report covers individual Immuno-Oncology Treatment players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Immuno-Oncology Treatment This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Ambulatory Surgical Center).

Technology Analysis: Report covers specific technologies relevant to Immuno-Oncology Treatment. It assesses the current state, advancements, and potential future developments in Immuno-Oncology Treatment areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Immuno-Oncology Treatment market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Immuno-Oncology Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    Immune Checkpoint Inhibitors
    Monoclonal Antibodies
    Cytokine-Based Immunotherapy
    Cancer Vaccines
    CAR-T Cell Therapy

Market segment by Application
    Hospitals
    Ambulatory Surgical Center
    Others

Market segment by players, this report covers
    Amgen
    AstraZeneca
    Bristol-Myers Squibb
    Eli-Lilly
    Roche
    GlaxoSmithKline
    Janssen Biotech
    Merck
    Novartis
    Pfizer
    Sanofi
    Spectrum Pharmaceuticals
    Takeda

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Immuno-Oncology Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immuno-Oncology Treatment, with revenue, gross margin and global market share of Immuno-Oncology Treatment from 2019 to 2024.
Chapter 3, the Immuno-Oncology Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Immuno-Oncology Treatment market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immuno-Oncology Treatment.
Chapter 13, to describe Immuno-Oncology Treatment research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Immuno-Oncology Treatment
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Immuno-Oncology Treatment by Type
        1.3.1 Overview: Global Immuno-Oncology Treatment Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Immuno-Oncology Treatment Consumption Value Market Share by Type in 2023
        1.3.3 Immune Checkpoint Inhibitors
        1.3.4 Monoclonal Antibodies
        1.3.5 Cytokine-Based Immunotherapy
        1.3.6 Cancer Vaccines
        1.3.7 CAR-T Cell Therapy
    1.4 Global Immuno-Oncology Treatment Market by Application
        1.4.1 Overview: Global Immuno-Oncology Treatment Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospitals
        1.4.3 Ambulatory Surgical Center
        1.4.4 Others
    1.5 Global Immuno-Oncology Treatment Market Size & Forecast
    1.6 Global Immuno-Oncology Treatment Market Size and Forecast by Region
        1.6.1 Global Immuno-Oncology Treatment Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Immuno-Oncology Treatment Market Size by Region, (2019-2030)
        1.6.3 North America Immuno-Oncology Treatment Market Size and Prospect (2019-2030)
        1.6.4 Europe Immuno-Oncology Treatment Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Immuno-Oncology Treatment Market Size and Prospect (2019-2030)
        1.6.6 South America Immuno-Oncology Treatment Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Immuno-Oncology Treatment Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Amgen
        2.1.1 Amgen Details
        2.1.2 Amgen Major Business
        2.1.3 Amgen Immuno-Oncology Treatment Product and Solutions
        2.1.4 Amgen Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Amgen Recent Developments and Future Plans
    2.2 AstraZeneca
        2.2.1 AstraZeneca Details
        2.2.2 AstraZeneca Major Business
        2.2.3 AstraZeneca Immuno-Oncology Treatment Product and Solutions
        2.2.4 AstraZeneca Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 AstraZeneca Recent Developments and Future Plans
    2.3 Bristol-Myers Squibb
        2.3.1 Bristol-Myers Squibb Details
        2.3.2 Bristol-Myers Squibb Major Business
        2.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Product and Solutions
        2.3.4 Bristol-Myers Squibb Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.4 Eli-Lilly
        2.4.1 Eli-Lilly Details
        2.4.2 Eli-Lilly Major Business
        2.4.3 Eli-Lilly Immuno-Oncology Treatment Product and Solutions
        2.4.4 Eli-Lilly Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Eli-Lilly Recent Developments and Future Plans
    2.5 Roche
        2.5.1 Roche Details
        2.5.2 Roche Major Business
        2.5.3 Roche Immuno-Oncology Treatment Product and Solutions
        2.5.4 Roche Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Roche Recent Developments and Future Plans
    2.6 GlaxoSmithKline
        2.6.1 GlaxoSmithKline Details
        2.6.2 GlaxoSmithKline Major Business
        2.6.3 GlaxoSmithKline Immuno-Oncology Treatment Product and Solutions
        2.6.4 GlaxoSmithKline Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 GlaxoSmithKline Recent Developments and Future Plans
    2.7 Janssen Biotech
        2.7.1 Janssen Biotech Details
        2.7.2 Janssen Biotech Major Business
        2.7.3 Janssen Biotech Immuno-Oncology Treatment Product and Solutions
        2.7.4 Janssen Biotech Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Janssen Biotech Recent Developments and Future Plans
    2.8 Merck
        2.8.1 Merck Details
        2.8.2 Merck Major Business
        2.8.3 Merck Immuno-Oncology Treatment Product and Solutions
        2.8.4 Merck Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Merck Recent Developments and Future Plans
    2.9 Novartis
        2.9.1 Novartis Details
        2.9.2 Novartis Major Business
        2.9.3 Novartis Immuno-Oncology Treatment Product and Solutions
        2.9.4 Novartis Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Novartis Recent Developments and Future Plans
    2.10 Pfizer
        2.10.1 Pfizer Details
        2.10.2 Pfizer Major Business
        2.10.3 Pfizer Immuno-Oncology Treatment Product and Solutions
        2.10.4 Pfizer Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Pfizer Recent Developments and Future Plans
    2.11 Sanofi
        2.11.1 Sanofi Details
        2.11.2 Sanofi Major Business
        2.11.3 Sanofi Immuno-Oncology Treatment Product and Solutions
        2.11.4 Sanofi Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Sanofi Recent Developments and Future Plans
    2.12 Spectrum Pharmaceuticals
        2.12.1 Spectrum Pharmaceuticals Details
        2.12.2 Spectrum Pharmaceuticals Major Business
        2.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Product and Solutions
        2.12.4 Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Spectrum Pharmaceuticals Recent Developments and Future Plans
    2.13 Takeda
        2.13.1 Takeda Details
        2.13.2 Takeda Major Business
        2.13.3 Takeda Immuno-Oncology Treatment Product and Solutions
        2.13.4 Takeda Immuno-Oncology Treatment Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Takeda Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Immuno-Oncology Treatment Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Immuno-Oncology Treatment by Company Revenue
        3.2.2 Top 3 Immuno-Oncology Treatment Players Market Share in 2023
        3.2.3 Top 6 Immuno-Oncology Treatment Players Market Share in 2023
    3.3 Immuno-Oncology Treatment Market: Overall Company Footprint Analysis
        3.3.1 Immuno-Oncology Treatment Market: Region Footprint
        3.3.2 Immuno-Oncology Treatment Market: Company Product Type Footprint
        3.3.3 Immuno-Oncology Treatment Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Immuno-Oncology Treatment Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Immuno-Oncology Treatment Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Immuno-Oncology Treatment Consumption Value Market Share by Application (2019-2024)
    5.2 Global Immuno-Oncology Treatment Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Immuno-Oncology Treatment Consumption Value by Type (2019-2030)
    6.2 North America Immuno-Oncology Treatment Consumption Value by Application (2019-2030)
    6.3 North America Immuno-Oncology Treatment Market Size by Country
        6.3.1 North America Immuno-Oncology Treatment Consumption Value by Country (2019-2030)
        6.3.2 United States Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
        6.3.3 Canada Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
        6.3.4 Mexico Immuno-Oncology Treatment Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Immuno-Oncology Treatment Consumption Value by Type (2019-2030)
    7.2 Europe Immuno-Oncology Treatment Consumption Value by Application (2019-2030)
    7.3 Europe Immuno-Oncology Treatment Market Size by Country
        7.3.1 Europe Immuno-Oncology Treatment Consumption Value by Country (2019-2030)
        7.3.2 Germany Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
        7.3.3 France Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
        7.3.5 Russia Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
        7.3.6 Italy Immuno-Oncology Treatment Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Immuno-Oncology Treatment Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Immuno-Oncology Treatment Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Immuno-Oncology Treatment Market Size by Region
        8.3.1 Asia-Pacific Immuno-Oncology Treatment Consumption Value by Region (2019-2030)
        8.3.2 China Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
        8.3.3 Japan Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
        8.3.4 South Korea Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
        8.3.5 India Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
        8.3.7 Australia Immuno-Oncology Treatment Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Immuno-Oncology Treatment Consumption Value by Type (2019-2030)
    9.2 South America Immuno-Oncology Treatment Consumption Value by Application (2019-2030)
    9.3 South America Immuno-Oncology Treatment Market Size by Country
        9.3.1 South America Immuno-Oncology Treatment Consumption Value by Country (2019-2030)
        9.3.2 Brazil Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
        9.3.3 Argentina Immuno-Oncology Treatment Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Immuno-Oncology Treatment Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Immuno-Oncology Treatment Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Immuno-Oncology Treatment Market Size by Country
        10.3.1 Middle East & Africa Immuno-Oncology Treatment Consumption Value by Country (2019-2030)
        10.3.2 Turkey Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Immuno-Oncology Treatment Market Size and Forecast (2019-2030)
        10.3.4 UAE Immuno-Oncology Treatment Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Immuno-Oncology Treatment Market Drivers
    11.2 Immuno-Oncology Treatment Market Restraints
    11.3 Immuno-Oncology Treatment Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Immuno-Oncology Treatment Industry Chain
    12.2 Immuno-Oncology Treatment Upstream Analysis
    12.3 Immuno-Oncology Treatment Midstream Analysis
    12.4 Immuno-Oncology Treatment Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Immuno-Oncology Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Immuno-Oncology Treatment Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Immuno-Oncology Treatment Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Immuno-Oncology Treatment Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Amgen Company Information, Head Office, and Major Competitors
    Table 6. Amgen Major Business
    Table 7. Amgen Immuno-Oncology Treatment Product and Solutions
    Table 8. Amgen Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Amgen Recent Developments and Future Plans
    Table 10. AstraZeneca Company Information, Head Office, and Major Competitors
    Table 11. AstraZeneca Major Business
    Table 12. AstraZeneca Immuno-Oncology Treatment Product and Solutions
    Table 13. AstraZeneca Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. AstraZeneca Recent Developments and Future Plans
    Table 15. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
    Table 16. Bristol-Myers Squibb Major Business
    Table 17. Bristol-Myers Squibb Immuno-Oncology Treatment Product and Solutions
    Table 18. Bristol-Myers Squibb Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Bristol-Myers Squibb Recent Developments and Future Plans
    Table 20. Eli-Lilly Company Information, Head Office, and Major Competitors
    Table 21. Eli-Lilly Major Business
    Table 22. Eli-Lilly Immuno-Oncology Treatment Product and Solutions
    Table 23. Eli-Lilly Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. Eli-Lilly Recent Developments and Future Plans
    Table 25. Roche Company Information, Head Office, and Major Competitors
    Table 26. Roche Major Business
    Table 27. Roche Immuno-Oncology Treatment Product and Solutions
    Table 28. Roche Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. Roche Recent Developments and Future Plans
    Table 30. GlaxoSmithKline Company Information, Head Office, and Major Competitors
    Table 31. GlaxoSmithKline Major Business
    Table 32. GlaxoSmithKline Immuno-Oncology Treatment Product and Solutions
    Table 33. GlaxoSmithKline Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. GlaxoSmithKline Recent Developments and Future Plans
    Table 35. Janssen Biotech Company Information, Head Office, and Major Competitors
    Table 36. Janssen Biotech Major Business
    Table 37. Janssen Biotech Immuno-Oncology Treatment Product and Solutions
    Table 38. Janssen Biotech Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 39. Janssen Biotech Recent Developments and Future Plans
    Table 40. Merck Company Information, Head Office, and Major Competitors
    Table 41. Merck Major Business
    Table 42. Merck Immuno-Oncology Treatment Product and Solutions
    Table 43. Merck Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 44. Merck Recent Developments and Future Plans
    Table 45. Novartis Company Information, Head Office, and Major Competitors
    Table 46. Novartis Major Business
    Table 47. Novartis Immuno-Oncology Treatment Product and Solutions
    Table 48. Novartis Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 49. Novartis Recent Developments and Future Plans
    Table 50. Pfizer Company Information, Head Office, and Major Competitors
    Table 51. Pfizer Major Business
    Table 52. Pfizer Immuno-Oncology Treatment Product and Solutions
    Table 53. Pfizer Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 54. Pfizer Recent Developments and Future Plans
    Table 55. Sanofi Company Information, Head Office, and Major Competitors
    Table 56. Sanofi Major Business
    Table 57. Sanofi Immuno-Oncology Treatment Product and Solutions
    Table 58. Sanofi Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 59. Sanofi Recent Developments and Future Plans
    Table 60. Spectrum Pharmaceuticals Company Information, Head Office, and Major Competitors
    Table 61. Spectrum Pharmaceuticals Major Business
    Table 62. Spectrum Pharmaceuticals Immuno-Oncology Treatment Product and Solutions
    Table 63. Spectrum Pharmaceuticals Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 64. Spectrum Pharmaceuticals Recent Developments and Future Plans
    Table 65. Takeda Company Information, Head Office, and Major Competitors
    Table 66. Takeda Major Business
    Table 67. Takeda Immuno-Oncology Treatment Product and Solutions
    Table 68. Takeda Immuno-Oncology Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 69. Takeda Recent Developments and Future Plans
    Table 70. Global Immuno-Oncology Treatment Revenue (USD Million) by Players (2019-2024)
    Table 71. Global Immuno-Oncology Treatment Revenue Share by Players (2019-2024)
    Table 72. Breakdown of Immuno-Oncology Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 73. Market Position of Players in Immuno-Oncology Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 74. Head Office of Key Immuno-Oncology Treatment Players
    Table 75. Immuno-Oncology Treatment Market: Company Product Type Footprint
    Table 76. Immuno-Oncology Treatment Market: Company Product Application Footprint
    Table 77. Immuno-Oncology Treatment New Market Entrants and Barriers to Market Entry
    Table 78. Immuno-Oncology Treatment Mergers, Acquisition, Agreements, and Collaborations
    Table 79. Global Immuno-Oncology Treatment Consumption Value (USD Million) by Type (2019-2024)
    Table 80. Global Immuno-Oncology Treatment Consumption Value Share by Type (2019-2024)
    Table 81. Global Immuno-Oncology Treatment Consumption Value Forecast by Type (2025-2030)
    Table 82. Global Immuno-Oncology Treatment Consumption Value by Application (2019-2024)
    Table 83. Global Immuno-Oncology Treatment Consumption Value Forecast by Application (2025-2030)
    Table 84. North America Immuno-Oncology Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 85. North America Immuno-Oncology Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 86. North America Immuno-Oncology Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 87. North America Immuno-Oncology Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 88. North America Immuno-Oncology Treatment Consumption Value by Country (2019-2024) & (USD Million)
    Table 89. North America Immuno-Oncology Treatment Consumption Value by Country (2025-2030) & (USD Million)
    Table 90. Europe Immuno-Oncology Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 91. Europe Immuno-Oncology Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 92. Europe Immuno-Oncology Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 93. Europe Immuno-Oncology Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 94. Europe Immuno-Oncology Treatment Consumption Value by Country (2019-2024) & (USD Million)
    Table 95. Europe Immuno-Oncology Treatment Consumption Value by Country (2025-2030) & (USD Million)
    Table 96. Asia-Pacific Immuno-Oncology Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 97. Asia-Pacific Immuno-Oncology Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 98. Asia-Pacific Immuno-Oncology Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 99. Asia-Pacific Immuno-Oncology Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 100. Asia-Pacific Immuno-Oncology Treatment Consumption Value by Region (2019-2024) & (USD Million)
    Table 101. Asia-Pacific Immuno-Oncology Treatment Consumption Value by Region (2025-2030) & (USD Million)
    Table 102. South America Immuno-Oncology Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 103. South America Immuno-Oncology Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 104. South America Immuno-Oncology Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 105. South America Immuno-Oncology Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 106. South America Immuno-Oncology Treatment Consumption Value by Country (2019-2024) & (USD Million)
    Table 107. South America Immuno-Oncology Treatment Consumption Value by Country (2025-2030) & (USD Million)
    Table 108. Middle East & Africa Immuno-Oncology Treatment Consumption Value by Type (2019-2024) & (USD Million)
    Table 109. Middle East & Africa Immuno-Oncology Treatment Consumption Value by Type (2025-2030) & (USD Million)
    Table 110. Middle East & Africa Immuno-Oncology Treatment Consumption Value by Application (2019-2024) & (USD Million)
    Table 111. Middle East & Africa Immuno-Oncology Treatment Consumption Value by Application (2025-2030) & (USD Million)
    Table 112. Middle East & Africa Immuno-Oncology Treatment Consumption Value by Country (2019-2024) & (USD Million)
    Table 113. Middle East & Africa Immuno-Oncology Treatment Consumption Value by Country (2025-2030) & (USD Million)
    Table 114. Immuno-Oncology Treatment Raw Material
    Table 115. Key Suppliers of Immuno-Oncology Treatment Raw Materials
List of Figures
    Figure 1. Immuno-Oncology Treatment Picture
    Figure 2. Global Immuno-Oncology Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Immuno-Oncology Treatment Consumption Value Market Share by Type in 2023
    Figure 4. Immune Checkpoint Inhibitors
    Figure 5. Monoclonal Antibodies
    Figure 6. Cytokine-Based Immunotherapy
    Figure 7. Cancer Vaccines
    Figure 8. CAR-T Cell Therapy
    Figure 9. Global Immuno-Oncology Treatment Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 10. Immuno-Oncology Treatment Consumption Value Market Share by Application in 2023
    Figure 11. Hospitals Picture
    Figure 12. Ambulatory Surgical Center Picture
    Figure 13. Others Picture
    Figure 14. Global Immuno-Oncology Treatment Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 15. Global Immuno-Oncology Treatment Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 16. Global Market Immuno-Oncology Treatment Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 17. Global Immuno-Oncology Treatment Consumption Value Market Share by Region (2019-2030)
    Figure 18. Global Immuno-Oncology Treatment Consumption Value Market Share by Region in 2023
    Figure 19. North America Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 20. Europe Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 21. Asia-Pacific Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 22. South America Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 23. Middle East and Africa Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 24. Global Immuno-Oncology Treatment Revenue Share by Players in 2023
    Figure 25. Immuno-Oncology Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 26. Global Top 3 Players Immuno-Oncology Treatment Market Share in 2023
    Figure 27. Global Top 6 Players Immuno-Oncology Treatment Market Share in 2023
    Figure 28. Global Immuno-Oncology Treatment Consumption Value Share by Type (2019-2024)
    Figure 29. Global Immuno-Oncology Treatment Market Share Forecast by Type (2025-2030)
    Figure 30. Global Immuno-Oncology Treatment Consumption Value Share by Application (2019-2024)
    Figure 31. Global Immuno-Oncology Treatment Market Share Forecast by Application (2025-2030)
    Figure 32. North America Immuno-Oncology Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 33. North America Immuno-Oncology Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 34. North America Immuno-Oncology Treatment Consumption Value Market Share by Country (2019-2030)
    Figure 35. United States Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 36. Canada Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 37. Mexico Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 38. Europe Immuno-Oncology Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 39. Europe Immuno-Oncology Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 40. Europe Immuno-Oncology Treatment Consumption Value Market Share by Country (2019-2030)
    Figure 41. Germany Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 42. France Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 43. United Kingdom Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 44. Russia Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 45. Italy Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 46. Asia-Pacific Immuno-Oncology Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 47. Asia-Pacific Immuno-Oncology Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 48. Asia-Pacific Immuno-Oncology Treatment Consumption Value Market Share by Region (2019-2030)
    Figure 49. China Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 50. Japan Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 51. South Korea Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 52. India Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 53. Southeast Asia Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 54. Australia Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 55. South America Immuno-Oncology Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 56. South America Immuno-Oncology Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 57. South America Immuno-Oncology Treatment Consumption Value Market Share by Country (2019-2030)
    Figure 58. Brazil Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 59. Argentina Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 60. Middle East and Africa Immuno-Oncology Treatment Consumption Value Market Share by Type (2019-2030)
    Figure 61. Middle East and Africa Immuno-Oncology Treatment Consumption Value Market Share by Application (2019-2030)
    Figure 62. Middle East and Africa Immuno-Oncology Treatment Consumption Value Market Share by Country (2019-2030)
    Figure 63. Turkey Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 64. Saudi Arabia Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 65. UAE Immuno-Oncology Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 66. Immuno-Oncology Treatment Market Drivers
    Figure 67. Immuno-Oncology Treatment Market Restraints
    Figure 68. Immuno-Oncology Treatment Market Trends
    Figure 69. Porters Five Forces Analysis
    Figure 70. Manufacturing Cost Structure Analysis of Immuno-Oncology Treatment in 2023
    Figure 71. Manufacturing Process Analysis of Immuno-Oncology Treatment
    Figure 72. Immuno-Oncology Treatment Industrial Chain
    Figure 73. Methodology
    Figure 74. Research Process and Data Source

Companies Mentioned

Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda